182 related articles for article (PubMed ID: 16688680)
21. Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis.
Tada Y; Koarada S; Morito F; Mitamura M; Inoue H; Suematsu R; Ohta A; Miyake K; Nagasawa K
Arthritis Res Ther; 2008; 10(5):R121. PubMed ID: 18847495
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.
Sharkhuu T; Matthaei KI; Forbes E; Mahalingam S; Hogan SP; Hansbro PM; Foster PS
Clin Exp Allergy; 2006 Dec; 36(12):1575-83. PubMed ID: 17177681
[TBL] [Abstract][Full Text] [Related]
23. TH2 and TH1 lung inflammation induced by airway allergen sensitization with low and high doses of double-stranded RNA.
Jeon SG; Oh SY; Park HK; Kim YS; Shim EJ; Lee HS; Oh MH; Bang B; Chun EY; Kim SH; Gho YS; Zhu Z; Kim YY; Kim YK
J Allergy Clin Immunol; 2007 Oct; 120(4):803-12. PubMed ID: 17610940
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
25. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.
Nandakumar KS; Holmdahl R
J Immunol Methods; 2005 Sep; 304(1-2):126-36. PubMed ID: 16125192
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?
Dayer JM
J Rheumatol Suppl; 2002 Sep; 65():10-5. PubMed ID: 12236616
[TBL] [Abstract][Full Text] [Related]
28. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.
Plater-Zyberk C; Joosten LA; Helsen MM; Koenders MI; Baeuerle PA; van den Berg WB
Ann Rheum Dis; 2009 May; 68(5):721-8. PubMed ID: 18495731
[TBL] [Abstract][Full Text] [Related]
29. Dietary fish oil decreases secretion of T helper (Th) 1-type cytokines by a direct effect on murine splenic T cells but enhances secretion of a Th2-type cytokine by an effect on accessory cells.
Petursdottir DH; Hardardottir I
Br J Nutr; 2009 Apr; 101(7):1040-6. PubMed ID: 18680632
[TBL] [Abstract][Full Text] [Related]
30. IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system.
Ching S; He L; Lai W; Quan N
Brain Behav Immun; 2005 Mar; 19(2):127-37. PubMed ID: 15664785
[TBL] [Abstract][Full Text] [Related]
31. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Kolls JK; Joosten LA; van den Berg WB
Arthritis Rheum; 2005 Mar; 52(3):975-83. PubMed ID: 15751058
[TBL] [Abstract][Full Text] [Related]
32. STAT6 deletion converts the Th2 inflammatory pathology afflicting Lat(Y136F) mice into a lymphoproliferative disorder involving Th1 and CD8 effector T cells.
Archambaud C; Sansoni A; Mingueneau M; Devilard E; Delsol G; Malissen B; Malissen M
J Immunol; 2009 Mar; 182(5):2680-9. PubMed ID: 19234162
[TBL] [Abstract][Full Text] [Related]
33. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
Bharhani MS; Chiu B; Na KS; Inman RD
Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
van de Loo FA; Kuiper S; van Enckevort FH; Arntz OJ; van den Berg WB
Am J Pathol; 1997 Jul; 151(1):177-91. PubMed ID: 9212744
[TBL] [Abstract][Full Text] [Related]
35. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice.
Probert L; Plows D; Kontogeorgos G; Kollias G
Eur J Immunol; 1995 Jun; 25(6):1794-7. PubMed ID: 7615010
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
37. Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis.
Wahle M; Hanefeld G; Brunn S; Straub RH; Wagner U; Krause A; Häntzschel H; Baerwald CG
Arthritis Res Ther; 2006; 8(5):R138. PubMed ID: 16889669
[TBL] [Abstract][Full Text] [Related]
38. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
[TBL] [Abstract][Full Text] [Related]
39. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
[TBL] [Abstract][Full Text] [Related]
40. Effect of sinomenine on collagen-induced arthritis in mice.
Feng H; Yamaki K; Takano H; Inoue K; Yanagisawa R; Yoshino S
Autoimmunity; 2007 Nov; 40(7):532-9. PubMed ID: 17966044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
